rs545954490
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001267550.2(TTN):c.76654C>T(p.Arg25552*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000372 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | MANE Select | c.76654C>T | p.Arg25552* | stop_gained | Exon 326 of 363 | NP_001254479.2 | ||
| TTN | NM_001256850.1 | c.71731C>T | p.Arg23911* | stop_gained | Exon 276 of 313 | NP_001243779.1 | |||
| TTN | NM_133378.4 | c.68950C>T | p.Arg22984* | stop_gained | Exon 275 of 312 | NP_596869.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | TSL:5 MANE Select | c.76654C>T | p.Arg25552* | stop_gained | Exon 326 of 363 | ENSP00000467141.1 | ||
| TTN | ENST00000446966.2 | TSL:1 | c.76498C>T | p.Arg25500* | stop_gained | Exon 324 of 361 | ENSP00000408004.2 | ||
| TTN | ENST00000436599.2 | TSL:1 | c.76378C>T | p.Arg25460* | stop_gained | Exon 324 of 361 | ENSP00000405517.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 247864 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460496Hom.: 0 Cov.: 40 AF XY: 0.00000551 AC XY: 4AN XY: 726398 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74376 show subpopulations
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg25552*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (rs545954490, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with clinical features of dilated cardiomyopathy (PMID: 30847666; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg22984*. ClinVar contains an entry for this variant (Variation ID: 404828). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). For these reasons, this variant has been classified as Pathogenic.
Dilated cardiomyopathy 1G Pathogenic:1
This variant is classified as Pathogenic. Evidence in support of pathogenic classification: Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction); Variant is present in gnomAD <0.001 for a dominant condition (v4: 6 heterozygote(s), 0 homozygote(s)); This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic or pathogenic by clinical laboratories in ClinVar, and has been reported in the literature in individuals with cardiomyopathy (PMIDs: 30847666, 36166435); Other NMD-predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity (ClinVar). Additional information: This variant is heterozygous; This gene is associated with both recessive and dominant disease (OMIM); Variant is located in the annotated A-band and the exon has a PSI score of 100% (PMID: 25589632); Loss of function is known mechanism of disease in this gene. In addition, dominant-negative is also a suggested mechanism. (PMID: 25589632); The condition associated with this gene has incomplete penetrance. Variants in this gene that result in a premature truncating codon (PTC) are known to have reduced penetrance in DCM (PMID: 25589632); Inheritance information for this variant is not currently available in this individual.
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
not provided Pathogenic:1
Cardiovascular phenotype Pathogenic:1
The p.R16487* variant (also known as c.49459C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 49459. This changes the amino acid from an arginine to a stop codon within coding exon 153. This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (also referred to as NM_133378.4:c.68950C>T, p.Arg22984* and NM_001256850.1:c.71731C>T, p.Arg23911Ter) has been detected in an individual with unspecified cardiomyopathy, and in an individual with idiopathic dilated cardiomyopathy (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309; Trachoo O et al. PLoS One. 2022 Sep;17(9):e0267770). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This variant is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53; Akhtar MM et al. Circ Heart Fail, 2020 Oct;13:e006832; Massier M et al. Clin Genet, 2025 Jan). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at